Tuberculosis vaccine development: strength lies in tenacity

Trends in Immunology
Stefan H E Kaufmann

Abstract

The past decade has witnessed a tremendous increase in the development of novel vaccines against tuberculosis (TB). In mice, each of these vaccine candidates stimulates an immune response that reduces the bacillary load, reflecting control but not sterilization of infection. Yet, the immune mechanisms underlying vaccine efficacy are only partially understood. In parallel to clinical assessment of current candidates, the next generation of vaccine candidates still needs to be developed. This requires basic research on how to induce the most efficacious immune response. Equally important is the dissection of immune responses in patients, latently infected healthy individuals, and participants of clinical vaccine trials. Amalgamation of this information will foster the way towards more efficacious vaccination strategies that not only prevent disease, but prevent or abolish infection.

References

Oct 12, 2001·Toxicon : Official Journal of the International Society on Toxinology·M Palmer
Apr 26, 2002·Trends in Microbiology·Michael J Brennan, Giovanni Delogu
Nov 29, 2002·Nature Genetics·Mark E J WoolhouseBruce R Levin
Jul 23, 2003·Nature Medicine·Ulrich E SchaibleStefan H E Kaufmann
Oct 19, 2004·Annual Review of Microbiology·Olivier DussurgetPascale Cossart
Jun 2, 2005·Nature Reviews. Immunology·Gennaro De Libero, Lucia Mori
Sep 1, 2005·Apoptosis : an International Journal on Programmed Cell Death·F WinauU E Schaible
Oct 22, 2005·Nature Immunology·Stefan H E Kaufmann, Florian Winau
Dec 20, 2005·The Journal of Pathology·Timo Ulrichs, Stefan H E Kaufmann
Jan 18, 2006·Immunity·Florian WinauUlrich E Schaible
Jun 20, 2006·Current Opinion in Immunology·Vojo Deretic
Dec 13, 2006·Nature Genetics·Daniel C JeffaresMatthew Berriman
May 8, 2007·Proceedings of the National Academy of Sciences of the United States of America·Simone A JoostenTom H M Ottenhoff
Sep 14, 2007·Immunological Reviews·Kyle RohdeDavid G Russell
Oct 13, 2007·Expert Review of Vaccines·Karen LingnauAlexander von Gabain
Jan 5, 2008·Annual Review of Immunology·Mary E KeirArlene H Sharpe
Jan 16, 2008·Expert Opinion on Biological Therapy·Jesus A Gonzalo AsensioCarlos Martin
Jan 10, 2009·Annual Review of Immunology·Thomas KornVijay K Kuchroo
Mar 14, 2009·European Journal of Immunology·Paul J Maglione, John Chan
Mar 24, 2009·Annual Review of Immunology·Andrea M Cooper
Mar 24, 2009·Annual Review of Immunology·Yasmine Belkaid, Kristin Tarbell
Aug 4, 2009·Current Opinion in Immunology·Anca Dorhoi, Stefan H E Kaufmann
Nov 3, 2009·International Journal of Pharmaceutics·Dennis ChristensenHanne Mørck Nielsen
Jan 12, 2010·Human Vaccines·Adrian V S HillSimon J Draper
Feb 20, 2010·American Journal of Respiratory and Critical Care Medicine·Brian AbelWillem A Hanekom
Mar 3, 2010·Annual Review of Immunology·Jinfang ZhuWilliam E Paul
May 22, 2010·Lancet·Stefan H E KaufmannPaul-Henri Lambert
May 25, 2010·Nature Genetics·Iñaki ComasSebastien Gagneux

❮ Previous
Next ❯

Citations

Dec 7, 2013·Biology Direct·Sandeep Kumar DhandaGajendra P S Raghava
Feb 5, 2013·Future Microbiology·Lola V Stamm, Benjamin Mudrak
May 14, 2014·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Simon BlankleyAnne O'Garra
Jan 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Niels Peter H KnudsenClaus Aagaard
May 24, 2014·Molecular Immunology·Md Kawsar KhanZeba I Seraj
Apr 1, 2014·The Journal of Veterinary Medical Science·Duanne Alves Da SilvaAndré Kipnis
Mar 23, 2013·Annual Review of Immunology·Anne O'GarraMatthew P R Berry
Jan 1, 2013·Vaccines·Kamalakannan VelmuruganMichael J Brennan
Nov 8, 2013·Expert Review of Vaccines·Dessislava MarinovaCarlos Martin
Dec 22, 2012·Microbial Pathogenesis·Jonathan M PittAnne O'Garra
Jan 22, 2013·Respirology : Official Journal of the Asian Pacific Society of Respirology·Charles C WangYing Zhang
Aug 15, 2013·European Journal of Immunology·Yong Cheng, Jeffery S Schorey
Mar 24, 2016·Human Vaccines & Immunotherapeutics·Yu PangSuhua Zheng
Sep 20, 2015·Journal of Medical Microbiology·Anne-Laure BanulsSylvain Godreuil
Feb 25, 2014·Current Opinion in Immunology·Stefan H E KaufmannGiuseppe Del Giudice
Mar 17, 2015·Molecular Immunology·Huan ZhangLiurong Fang
Jan 18, 2013·Human Vaccines & Immunotherapeutics·Carlos R Zárate-BladésCelio L Silva
Jun 4, 2013·Current Opinion in Immunology·Stefan H E Kaufmann, Anca Dorhoi
May 28, 2013·Seminars in Immunology·Stefan H E Kaufmann
Dec 3, 2014·Tuberculosis·Nicola Principi, Susanna Esposito
Oct 24, 2014·Frontiers in Microbiology·Mᵃdel Mar Serra-VidalJosé Domínguez
Sep 21, 2016·Artificial Cells, Nanomedicine, and Biotechnology·Yousef AminiMahdi Fasihi-Ramandi
Jan 25, 2017·Infection and Immunity·Alison J JohnsonSteven A Porcelli
Jan 16, 2015·Clinical and Vaccine Immunology : CVI·Kamlesh BhattPadmini Salgame
May 8, 2014·EMBO Molecular Medicine·Isabel DelanyEnnio De Gregorio
Sep 29, 2020·Applied Biochemistry and Microbiology·N I NadolinskaiaA V Goncharenko
Oct 5, 2017·Frontiers in Immunology·Natalie E NieuwenhuizenStefan H E Kaufmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.